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ABSTRACT Efforts to map neural circuits have been galvanized by the development of genetic technologies that permit the manipulation of
targeted sets of neurons in the brains of freely behaving animals. The success of these efforts relies on the experimenter’s ability to target
arbitrarily small subsets of neurons for manipulation, but such specificity of targeting cannot routinely be achieved using existing methods. In
Drosophila melanogaster, a widely-used technique for refined cell type-specific manipulation is the Split GAL4 system, which augments the
targeting specificity of the binary GAL4-UAS (Upstream Activating Sequence) system by making GAL4 transcriptional activity contingent upon
two enhancers, rather than one. To permit more refined targeting, we introduce here the “Killer Zipper” (KZip+), a suppressor that makes
Split GAL4 targeting contingent upon a third enhancer. KZip+ acts by disrupting both the formation and activity of Split GAL4 heterodimers,
and we show how this added layer of control can be used to selectively remove unwanted cells from a Split GAL4 expression pattern or to
subtract neurons of interest from a pattern to determine their requirement in generating a given phenotype. To facilitate application of the
KZip+ technology, we have developed a versatile set of LexAop-KZip+ fly lines that can be used directly with the large number of LexA driver
lines with known expression patterns. KZip+ significantly sharpens the precision of neuronal genetic control available in Drosophila and may
be extended to other organisms where Split GAL4-like systems are used.
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ANIMAL nervous systems consist of large numbers ofhighly heterogeneous cells that often differ profoundly
in function (Luo et al. 2008). This functional heterogeneity rep-
resents a major challenge to understanding how nervous sys-
tems work because it requires analyzing the biological roles of
not one, or a few, neural cell types, but many. In the extreme
case, each individual neuron in an animal might need to be
selectively interrogated to determine its contribution to behav-
ior or other brain processes. Although routine analysis at this
level is not currently feasible except in animals with extremely
reduced nervous systems, it is increasingly possible to target
populations of neurons—often of a particular type—for func-
tional interrogation using genetic methods. Such methods have
been developed to facilitate neural circuit mapping in genetic
model organisms and have been used successfully for that pur-
pose in mice (Kitamura et al. 2014; Li et al. 2015), fish (Lacoste
et al. 2015), and fruit flies (Dubnau et al. 2001; Claridge-Chang
et al. 2009). Nevertheless, the number of circuits that have
yielded to this approach, and the resolution to which they have
been mapped, has been constrained by the limited ability of
existing methods to systematically and reproducibly target
small, cell type-specific neuronal populations. This is true even
in the fruit fly, Drosophila melanogaster, where currently avail-
able techniques can sometimes achieve single-cell resolution.
Most methods for the selective manipulation of cellu-
lar function in Drosophila build on the binary GAL4-UAS
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(Upstream Activating Sequence) system (Brand and Perrimon
1993; Pfeiffer et al. 2010). In this system, expression of the
GAL4 transcription factor is directed to specific cells using an
enhancer element of an endogenously expressed gene. Within
the targeted cells, GAL4 activates expression of transgenes
placed under the control of its UAS and the products of these
transgenes then alter neuronal function. While the GAL4-UAS
systemhas occasionally been successful in targeting small groups
of neurons, its targeting specificity is, in general, constrained by
the limited cell type selectivity of the neuronal gene enhancers
required to drive expression of GAL4 (Pfeiffer et al. 2008; Jenett
et al. 2012).
To provide greater selectivity of targeting, several ternary
expression systems have been developed that effectively re-
strict the activity of GAL4 to a population of neurons in which
two gene enhancers, rather than one, are required to be active
(Luan et al. 2006; Bohm et al. 2010; Potter et al. 2010; Ting
et al. 2011). This combinatorial strategy is the basis of
the Split GAL4 system, which is widely used for cell type-
restricted expression in the fly (Luan et al. 2006; Pfeiffer et al.
2010). In this system, the two enhancer elements are used to
independently target the GAL4 DNA-binding domain and a
complementary transcription activation domain to different
cell groups. Only in cells in which both enhancers are active
are the two transcription factor domains coexpressed. Each
domain is fused to one of a pair of heterodimerizing leucine
zippers (Zip– and Zip+), which allows them to come together
in coexpressing cells to reconstitute transcriptional activity
and drive the expression of UAS-transgenes.
The refinement of transgene expression afforded by the
Split GAL4 system has facilitated the targeting of single
neuronal cell types in an increasing number of cases (Luan
et al. 2012; Kohl et al. 2013; Tuthill et al. 2013; Aso et al.
2014a,b; Bidaye et al. 2014; Diao et al. 2015; Hoopfer et al.
2015). However, this exquisite precision has proved difficult
to achieve consistently even using two enhancers. To im-
prove the targeting specificity of the Split GAL4 system, we
here introduce an additional mechanism of transcriptional
control similar to that provided by GAL80 in the binary
GAL4-UAS system (Lee and Luo 1999; Suster et al. 2004).
We have developed the “Killer Zipper” (KZip+), a dominant-
negative repressor of Split-GAL4 activity, which can be
expressed under the control of a third enhancer to exclude
defined cells from a Split GAL4 expression pattern. We vali-
date the efficacy of KZip+ constructs and demonstrate their
use in the refinement of Split GAL4 expression in the fly brain.
Materials and Methods
Molecular biology
All molecular biology was performed following standard
procedures (Maniatis et al. 2012) and either Gibson Isother-
mal Assembly (Gibson et al. 2009) or Gateway Cloning (Invi-
trogen, Carlsbad, CA). One Shot Mach1 T1 Phage-Resistant
Chemically Competent Escherichia coli (Life Technologies) or
Mix & Go Competent Cells - Strain Zymo 5a (Zymo Research,
Irvine, CA) were used for chemical transformations. DNA
was prepared using QIAprep Spin Miniprep or Midiprep
Kits (QIAGEN, Valencia, CA) and QIAquick Gel Extraction,
and PCR Purification Kits (QIAGEN) or Zymoclean Gel DNA
Recovery Kit (Zymo Research) were used to extract or purify
DNA fragments, respectively. All restriction enzymes were
purchased from New England Biolabs (NEB) (Beverly, MA).
Gibson Isothermal reaction mix was either purchased
(NEB) or created from a published recipe (Gibson et al.
2009). All plasmids were sequence-verified and sequenc-
ing services were provided by GATC (GATC Biotech AG,
Konstanz, Germany), Source Biosciences (Nottingham,
UK) or Macrogen (Rockville, MD). Oligonucleotide synthesis
was carried out by Integrated DNA Technologies (Coralville,
IA) and gene synthesis by Epoch Life Science (Sugar Land, TX).
CCAP-KZip+ and Burs-KZip+ constructs: KZip+ was made
from previously published components as described in Luan
et al. (2006) and placed behind CCAP (Crustacean Cardioac-
tive Peptide) and bursicon promoters (Burs) in the pCaST
X11 P-element transformation vector. Briefly, the Zip2 (i.e.,
RR12EE345L) moiety of the Zip2-GAL4DBD was replaced by
the Zip+ (i.e., EE12RR345L) moiety previously used to make
the GAL4AD-Zip+ and VP16AD-Zip+ constructs. The result-
ing KZip+ construct was inserted into the pCaST-CCAP-
GAL4DBD vector using flanking NotI and AscI restriction sites
to replace Zip2-GAL4DBD. This pCaST-CCAP-KZip+ vector
was then used to make pCaST-Burs-KZip + by replacing the
CCAP promoter with the previously described promoter of
the Burs (i.e., bursicon a) gene (Peabody et al. 2009) using
flanking EcoRI and NotI restriction sites.
The five KZip+ variants expressed under the control of
the CCAP promoter were prepared for FC31-mediated
transgenesis in a vector derived from pJFRC81-10XUAS-
IVS-Syn21-GFP-p10 (Pfeiffer et al. 2012). First, the unaltered
CCAP-KZip+ variant was made by replacing the 10XUAS-IVS-
Syn21-GFP-p10 sequence of this vector with the CCAP-KZip+
sequence from pCaST-CCAP-KZip+ together with the Simian
virus 40 transcription terminator. The sequence encoding
KZip+ in this vector is flanked by unique EagI and XbaI re-
striction sites, which allowed it to be replaced by similarly
flanked sequences encoding 4xKZip+, KZip+::HRD, and
KZip+::3xHA, respectively. The latter sequences were synthe-
sized by Epoch Life Science (Sugar Land, TX) and contain, in
order: a construct consisting of four tandem copies of KZip+
separated by viral T2A peptides; a C-terminal fusion of KZip+
to the Hairy Repressor Domain, an 18 aa peptide (i.e., Hairy
aa320–337) shown to repress transcriptional activity (Fisher
et al. 1996); and a C-terminal fusion of KZip+ to three copies
of the hemagglutinin epitope tag. A final variant, CCAP-IVS-
Syn21-KZip+-p10, retains the viral translational enhancers
of pJFRC81-10XUAS-IVS-Syn21-GFP-p10 and was derived
from that vector by replacing the 10XUAS sequence with that
of the CCAP promoter and the coding sequence of GFP with
that of the KZip+ construct.
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LexAop-KZip+ constructs: All LexAop-KZip+ constructs were
made in a vector derived from pJFRC19 (Pfeiffer et al. 2010).
LexAop-KZip+::3xHA was made by amplifying KZip+ from
pCaST-CCAP-KZip+ using PCR primers that also incorpo-
rated a 3xHA-tag at the C-terminus (pJFRC19/KZ_F and
pJFRC19/KZ::HA_R; Supplemental Material, Table S1).
These primers contained overhanging regions identical to
regions flanking the myrGFP ORF in pJFRC19 (Pfeiffer
et al. 2010). The pJFRC19 plasmid backbone was amplified
inversely without the myrGFP ORF (using pJFRC19inverse_F
and pJFRC19inverse_R primers, Table S1). The linearized,
pJFRC19 backbone was used for a Gibson Isothermal reac-
tion with the KZip+::3xHA PCR product to produce pLexAop-
KZip+::3xHA.
For the generation of all other constructs we switched to a
digestion strategy, as the PCR amplification of large plasmid
backbones rarely produced sufficient quantities for cloning.
The pLexAop-KZip+::3xHA vector was used to make subse-
quent constructs by first excising the KZip+::3xHA ORF by
restriction digestion with NotI-HF and XbaI, and then using
the resulting backbone (purified by gel extraction) for Iso-
thermal assembly together with a gel-extracted PCR product
corresponding to the KZip+ construct. For LexAop-KZip+, the
KZip+ PCR product was amplified from pLexAop- KZip+::3-
xHA using PCR primers that excluded the HA-tag (pJFRC19/
KZip+_F and pJFRC19_Stop_ KZip+_R; Table S1). For
nucLacZ-T2A-KZip+, the PCR product was amplified from a
synthesized gene placed in the pMA vector (pMA-nucLacZ-
T2A-KZip+; GeneArt, Thermo Fisher) using the pMA-LacZ_F
and pMA- KZip+_R primers (Table S1). nucLacZ represents a
fusion of the LacZ gene a nuclear targeting sequence and T2A
is the 2A peptide from Thosea asigna, which promotes ribo-
somal skipping. By placing the LacZ gene before the T2A se-
quence we ensured minimal disruption of the KZip+ protein
sequence, replacing only the N-terminal methionine with a
proline residue.
Fly stocks
All transgenic fly lines were created either by P element-
mediated orFC31-mediated transgenesis via embryonicmicro-
injection, which was performed by Rainbow Transgenic Flies
(Camarillo, CA) or BestGene (Chino Hills, CA). The chromo-
somes (for P-element insertions) or sites (for FC31-mediated
transgenesis) of insertion for the various lines made, as well
as the constructs used, are as listed in Table S1. The CCAP-
KZip+ and Burs-KZip+ made by P-element transgenesis were
initially screened for efficacy by crossing to “tester lines” of the
following general genotype: (y)w1118; UAS-Reporter/effector;
elav-VP16ADG3A1, CCAP-GAL4DBDK5A1/TM6b, where the
UAS-driven constructs were: 2XEGFP, 2XEKO, or NaChBacB-16.
Expression of either 2XEKO or NaChBacB-16 has previously
been shown to cause an unexpanded wing phenotype,
and progeny were scored for suppression of this pheno-
type. Lines that gave high levels of suppression of ei-
ther the unexpanded wing phenotype or enhanced GFP
(EGFP) reporter expression when examined by fluorescence
microscopy in CNS wholemounts, were selected for the
experiments shown.
Previously described stocks used in this study include: yw,
ShawMI01735-p65AD (Diao et al. 2015), w; +; UAS-TRPM8C4-A
(Peabody et al. 2009) (note that TRPM8 in the C4-A stock is
tagged with EGFP at the N-terminus, although this detail was
unwittingly omitted in the original publication), w; +; elav-
GAL4DBDH4A1 (Luan et al. 2006), w; +; CCAP-GAL4DBD
(Luan et al. 2006), w;IF/CyO;Nsyb-LexA (VK00037) (Pfeiffer
et al. 2010), yw,UAS-CD8::GFP;UAS-CD8::GFP;JK1029-AD,
ChaDBD/TM6b (Kohl et al. 2013), w;if/Cyo;MB247-LexA/
Tm6b (Pitman et al. 2011), w,Repo-LexA (Lai and Lee
2006), w;UAS-CD8::GFP/CyO (Lee and Luo 1999), MB112C:
w;;(R93D10-p65ADZp (VK00027), R13F04-ZpGAL4DBD in
attP2) (Aso et al. 2014a), and teashirt-LexA/Cyo;TM6b/MKRS
(kindly provided by J.-M. Knapp and J. Simpson). In addi-
tion, two Split-GAL4 lines not previously described were
used in this study. One (w;;JK801-VP16AD, SF131-DBD)
expresses in a Lateral Horn cell type and in many glia
throughout the brain. A second (w;126E12-ADp65;103H02-
DBD) drives in the larval central brain and ventral nerve
cord (VNC).
Immunohistochemistry
Whole-mount immunohistochemistry was performed essen-
tially as described before (Luan et al. 2012; Ostrovsky et al.
2013). The primary antibodies used were: 1:20 mouse anti-
nc82 (DSHB, University of Iowa), 1/1600 chicken anti-GFP
(Abcam, Cambridge, UK), 1/400 rabbit anti-HA (Cell Signal-
ing Technology, Danvers, MA), 1/400 mouse anti-b-galacto-
sidase (Abcam), 1:3000 rabbit anti-CCAP (Jena Bioscience,
Jena, Germany), and 1:100 mouse anti-GFP (Thermo Fisher,
Waltham, MA). The secondary antibodies used were all
purchased from Life Technologies, now Thermo Fisher:
Alexa-568 anti-mouse (for nc82 or b-galactosidase staining),
Alexa-633 anti-mouse IgG1 (for nc82 staining), Alexa-488
anti-chicken (for anti-GFP or anti-mVenus staining), Alexa-
488 anti-mouse (for anti-GFP staining), Alexa-568 anti-rab-
bit (for HA staining), and Alexa-555 anti-rabbit (for CCAP
staining). All secondary antibodies were raised in goat and
used at 1/1600 concentration, and all specimensweremounted
in Vectashield (Vector Laboratories, Burlingame, CA).
In all experiments, control and experimental preparations
(i.e., 6KZip+) were processed entirely in parallel to permit
direct comparison of the results. Also, except for the optimi-
zation experiments shown in Figure S1, UAS-reporter expres-
sion was amplified by immunostaining using anti-GFP to
stringently test for suppression of Split GAL4 activity by
KZip+. Anti-GFP immunostaining was not used in the optimi-
zation experiments in which it was important to accurately
compare the efficacy of the five CCAP-KZip+ variants made
byFC31-mediated transgenesis (Groth et al. 2004). To do so,
the CNSs of newly eclosed flies were excised and mounted
after fixation as described previously (Luan et al. 2012). All
whole-mount preparations were imaged using a Nikon C-1
confocal microscope and a 20 3 objective under the same
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conditions. To estimate the efficacy of each KZip+ variant in
suppressing CCAP-GAL4DBD\elav-VP16AD-driven expression
of UAS-2XEGFP, we quantified the residual labeling of the
CCAP-expressing neurons as follows: For each of 6–9 prepa-
rations imaged as described above, maximum intensity pro-
jections of the Z-stacks were examined and the intensity of
EGFP signal for each labeled CCAP neuron cell body was
scored on a scale of 1–3, with one being low-level labeling
and three being high-level labeling. The average number of
EGFP-positive CCAP neurons was then calculated for the CNS
preparations of each genotype together with the average in-
tensity of the labeled cells.
Wing expansion assay
Flies were raised at 25 and analyzed immediately after
eclosion for the time taken to expand their wings under con-
ditions of confinement, as described previously (Peabody
et al. 2009). Briefly, progeny from crosses listed below were
immediately confined in a minichamber (Peabody et al.
2009) and then placed on a Peltier plate at 25 or 18 and
videorecorded until wing expansion. Expansion time was
measured as the time from eclosion until the wings had com-
pletely expanded and were folded over the back.
Statistics
For all experiments, thenumber of observations is indicated in
thefigure legend.Eachexperimentwas repeatedat least twice
with independent groups of flies.
For the wing expansion data in Figure 5, a Levene test
indicated the data were heteroscedastic. The sample size
for each experiment is indicated in the corresponding figure
legend. No power analysis was performed to determine sam-
ple size, rather the sample sizes used were similar to those in
previous work describing neurogenetic tools (Pfeiffer et al.
2010; Potter et al. 2010; Riabinina et al. 2015) and wing
expansion experiments (Peabody et al. 2009; Luan et al.
2012). Significant differences between samples were demon-
strated using a Welch’s One Way ANOVA (P , 2.2e–16),
where P, 0.05 was declared significant. Three Welch t-tests
were conducted between the temperature levels for each ge-
notype and the P-values were adjusted using the Bonferroni
correction. Outliers were not excluded from analysis.
Data availability
KZip+ constructs and fly lines are available upon request.




Two transcriptional activators are commonly used in the
Split GAL4 system: p65AD-zip+ (Pfeiffer et al. 2010) and
dVP16AD-zip+ (Gao et al. 2008), the latter an optimized
variant of the VP16AD-zip+ construct introduced with the
original system (Luan et al. 2006). Neither of these activation
domains is targeted by a natural inhibitor in the way that
GAL80 targets the GAL4AD in yeast (Suster et al. 2004),
and the GAL4AD itself delivers comparatively weak transcrip-
tional activity in the Split GAL4 system (Luan et al. 2006;
Diao et al. 2015). In the absence of methods for suppressing
Split GAL4 activity by targeting the activation domains, we
therefore sought a method that acts on the zip2-GAL4DBD
domain common to all optimized activation domains (ADs).
The active GAL4 molecule exists as a homodimer, and paired
DNA-binding domains are required for recognition of the
UAS. We therefore reasoned that a zip+-GAL4DBD construct
(i.e., a GAL4DBD fused to the zip+ zipper, which is comple-
mentary to zip2 zipper to which the GAL4DBD is normally
Figure 1 Mechanism of Killer Zipper (KZip+)
suppression of Split GAL4 activity. (A) The Split
GAL4 system consists of functionally distinct
transcriptional components, a GAL4 DNA-
binding domain (GAL4DBD), and a transcrip-
tion activation domain (AD), each fused to a
heterodimerizing leucine zipper (Zip2 or Zip+).
Each component can be placed under the
control of a different promoter (P1 or P2)
resulting in two hemidriver lines, which drive
the transcriptional components in different
populations of cells. When the hemidrivers
are combined, Zip+ and Zip– dimerize in cells
expressing both components, producing a
functional Split GAL4 transcription factor ca-
pable of transcribing Upstream Activating
Sequence (UAS)-transgenes. (B) KZip+ (Zip+
-GAL4DBD) consists of the GAL4DBD frag-
ment fused to the Zip+ leucine zipper and
can be expressed either directly under the
control of a third promoter (P3) or indirectly
under such control by a LexA driver (LexAop). In cells that express the Split GAL4 components as well as KZip+, the latter molecule can form homodimers
with the Zip2-GAL4DBD and thus titrate GAL4DBD partners for the Zip+-AD. Furthermore, the homodimers can compete for binding to UAS sites and
block transcription by residual functional Split GAL4 heterodimers.
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fused), would bind the zip2-GAL4DBD to promote formation
of inactive GAL4DBD homodimers, with the capacity to bind
DNA without promoting transcription. In the presence of
zip+-AD molecules the zip+-GAL4DBD would additionally
compete with zip+-AD for binding to zip2-GAL4DBD,
and thus attenuate formation of transcriptionally active
zip2-GAL4DBD-AD-zip+molecules.We call the zip+-GAL4DBD
molecule the KZip+ by virtue of its leucine zipper-mediated
neutralization of zip2-GAL4DBD’s activity within the Split
GAL4 system (Figure 1).
KZip+ efficiently blocks split GAL4-mediated transcription
To evaluate the KZip+ we first tested inhibition of Split GAL4
activity in a small group of well-characterized neurons that
express CCAP. A subset of these cells coexpress the gene
encoding the Bursa subunit of the dimeric hormone bursicon
and are implicated in wing expansion, a process that con-
cludes metamorphosis (Peabody et al. 2009). Using the en-
hancers for the CCAP and Bursa genes, we created CCAP- and
Bursa-KZip+ constructs (Figure S1A) and generated trans-
genic fly lines by P-element-mediated transgenesis. For both
constructs, we identified lines that potently suppressed Split
GAL4 activity in the targeted neurons (Figure 2). CCAP-
KZip+ blocked EGFP reporter expression in CCAP-expressing
neurons (Figure 2A; note that the genotypes used in all
experiments are listed by figure in File S1). Similarly,
Bursa-KZip+ suppressed Split GAL4 activity in the bursicon-
expressing subset of the CCAP neurons, as evidenced by re-
moval of all EGFP expression in the neurons immunopositive
for bursicon (Figure 2B). In separate experiments, we tested
the ability of the KZip+ to inhibit activity of intact GAL4 in
bursicon-expressing neurons using the CCAP-GAL4 driver
and found substantial but not complete suppression, suggesting
Figure 2 The KZip+ construct robustly suppresses Split GAL4-mediated
transgene expression. (A) Left: Confocal projection view of a wholemount
adult CNS showing the CCAP-expressing neurons visualized by a
UAS-2xEGFP reporter (green) driven by a Split GAL4 driver (CCAP-
GAL4DBD\elav-VP16AD). Right: Reporter expression is substantially
suppressed when the KZip+ is coexpressed in the CCAP neurons. Each
image is a representative of n = 8 brains per genotype (the genotypes
used in the experiments shown in all figures are listed in File S1; here, and
in all subsequent figures, UAS-reporter expression has been amplified by
anti-GFP immunostaining to stringently test for suppression of Split GAL4
activity by KZip+). (B) Left: CCAP neurons expressing 2xEGFP (green) as in
(A), but double-labeled with anti-Burs antibody (magenta; double-labeled
neurons appear white). Right: Expression of KZip+ in the subset of CCAP
neurons that coexpresses the burs gene selectively blocks 2xEGFP expres-
sion in these neurons, which now label only in magenta (asterisks). Bar,
50 mm for all images in (A) and (B). Each image is a representative of n =
14 brains per genotype. (C) Top: the wings of newly emerged flies are
initially furled and become expanded upon execution of a behavioral
program governed by the hormone bursicon. The bursicon-induced pro-
gram is usually executed within the first 30 min of emergence, but is
substantially delayed if flies are confined. Confined flies, however, also
expand quickly if the complement of CCAP-expressing neurons that ex-
press bursicon is artificially stimulated by activation of the cold-sensitive
TRPM8 cation channel. Bottom: Box plots indicate the expansion times of
control flies that lack the CCAP-AD hemidriver (left), or flies expressing
UAS-TRPM8 in the CCAP-expressing neurons under the control of Split
GAL4 (CCAP-AD\CCAP-DBD . UAS-TRPM8) either with (right) or with-
out (middle) KZip+ coexpression in the bursicon neurons. All flies were
subjected to a 15 min temperature shift to 18 to activate TRPM8. KZip+
expression in the bursicon-expressing neurons prevents their expression
of UAS-TRPM8 and therefore their activation by temperature shift. br,
brain; Burs, bursicon promoter; CCAP, Crustacean Cardioactive Peptide;
EGFP, enhanced GFP; KZip+, Killer Zipper; UAS, Upstream Activating Se-
quence; vnc, ventral nerve cord.
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that KZip+ homodimers may inhibit GAL4 binding to UAS sites
(data not shown).
Acute activation of bursicon-expressing neurons with the
cold-sensitive ion channel TRPM8 induces rapid wing expan-
sion in recently eclosed adult flies (Luan et al. 2012). We
tested whether Bursa-KZip+ could similarly block this accel-
eration of wing expansion when UAS-TRPM8 expression was
driven in CCAP-expressing neurons by Split GAL4. We found
that a single copy of Bursa-KZip+ fully blocked the effects of
TRPM8-mediated activation of the CCAP neurons (Figure
2C), returning the time to wing expansion to wild-type levels
(Luan et al. 2012). These data demonstrate the utility of
KZip+ for functional studies involving Split GAL4-mediated
expression of effector transgenes. In addition, our results
demonstrate that only those CCAP-expressing neurons that
coexpress bursicon can induce wing expansion when
activated.
Optimizing the KZip+ construct
The above applications demonstrate the effectiveness of
KZip+. To determine whether its efficacy might be further
improved, we created variants of the KZip+ construct
designed to express KZip+ at elevated levels or to exhibit
enhanced transcriptional repression. To achieve the former
goal, we incorporated translational enhancers (Pfeiffer et al.
2012) into one construct (KZip+-p10) and tandem repeats
into another (4xKZip+), using the T2A peptide (Diao and
White 2012); to achieve the latter goal, we fused the repres-
sor domain of the transcriptional regulatorHairy (Fisher et al.
1996) to the KZip+ C-terminus (KZip+::HRD). In addition, to
facilitate detection of the expressed KZip+, we made and
tested a construct that contained a C-terminal triplet hemag-
glutinin tag (KZip+::3xHA). To systematically compare the
efficacy of these constructs, we tested their performance, to-
gether with that of the original KZip+ construct, under iden-
tical conditions. All constructs (Figure S1B) were placed
under the control of the CCAP promoter and inserted into
the same genomic locus (attP2 on chromosome III) using
FC31-mediated integration to control for position effects
(Groth et al. 2004). Although all KZip+ variants substantially
attenuated Split GAL4 activity, only the translationally en-
hanced KZip+-p10 construct showed greater efficacy than
the original KZip+ (Figure S1, C and D). It was particularly
surprising that the 4xKZip+ construct did not exhibit greater
inhibitory potential than KZip+ alone, but noteworthy that
three of the four KZip+ translation products produced by this
construct bear a C-terminal T2A-peptide tag (Donnelly et al.
2001). Both the KZip+::HRD and KZip+::3xHA constructs
also bear C-terminal fusions, and the reduced efficacy of
these constructs relative to KZip+ suggests that modifications
of the C-terminus may somewhat attenuate KZip+ function.
Generalized, amplified expression of KZip+ using
the LexA-system
These results demonstrate that KZip+ is capable of suppress-
ing Split GAL4 activity when expressed under the direct con-
trol of individual gene enhancers. However, this application
requires the creation of a new transgenic line for each en-
hancer, and the expression levels of KZip+ are constrained by
the transcriptional efficacy of that particular enhancer. To
provide a more general means of expressing KZip+ in distinct
patterns, we made and tested several “universal” constructs
(Figure S2A) that can be expressed in arbitrary sets of neu-
rons using the LexA-LexAop system (Lai and Lee 2006). This
binary system does not otherwise interfere with expression
driven by Split GAL4 (Lai and Lee 2006; Pfeiffer et al. 2010)
Figure 3 Killer Zipper (KZip+) expression driven by LexA drivers potently suppresses Split GAL4 activity. Adult brains from animals expressing Upstream
Activating Sequence (UAS)-reporters under the control of Split GAL4 drivers that express in populations of fru-expressing neurons (top; JK1029-
VP16AD\Cha-GAL4DBD) or Mushroom Body output neurons (MBON) (bottom; 93D10- p65AD\13F04-DBD). In both cases, reporter expression (green)
is shown in the absence (left) or presence (right) of one of the LexAop-KZip+ variants driven by the pan-neuronal n-syb-LexA driver (control preparations
on the left are from animals missing only the n-syb-LexA transgene, and are otherwise identical in genotype to those from experimental animals shown
on the right; each image is representative of n. 6 brains per genotype.) Complete suppression of reporter expression is seen with: (A) the LexAop-KZip+
construct, (B) the LexAop- KZip+::3xHA construct, and (C) the LexAop-LacZ-T2A-KZip+ construct. Reporters: UAS-EGFP and UAS-csChrimson::mVenus.
Bar, 30 mm.
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and a large number of well-characterized LexA drivers is now
available (http://flystocks.bio.indiana.edu/Browse/lexA/
lexA_Janelia.php), thus enabling the expression of KZip+ in
thousands of different neural populations across the fly brain.
We created several different LexAop-KZip+ constructs, in-
cluding versions both without (LexAop-KZip+) and with a
3xHA-tag (LexAop-KZip+::3xHA) to allow immunohisto-
chemical detection of expression (Figure S2B). Although in-
clusion of the C-terminal tag was expected to somewhat
reduce suppressor activity of KZip+ based on our optimiza-
tion experiments, we reasoned that amplified expression of
the construct by the LexA-LexAop system might compensate
for this reduction in activity. However, we also created an
alternative, untagged construct (LexAop-nLacZ-T2A-KZip+)
that permits visualization of KZip+ expression by coupling it
to that of nuclear-localized b-galactosidase, which can be de-
tected immunocytochemically or histologically (Figure S2C).
To test these lines, we selected two strong, previously
described Split GAL4 lines: Fru Split GAL4 (Cha-GAL4DBD\-
FruJK1029-VP16AD Kohl et al. 2013) and a Mushroom
Body Output Neuron (MBON)-specific Split GAL4 (R13F04-
GAL4DBD\R93D10-p65AD Aso et al. 2014a,b). For both
lines, all three LexAop-KZip+ constructs (including LexAop-
KZip+::3xHA), completely abolished expression of the UAS
reporter when expressed in all neurons under the control of
a pan-neuronal LexA driver (Figure 3). These results indi-
cate that KZip+ retains high efficacy when used with the
LexA system. Together, these examples also test all com-
monly used Split GAL4 DBD and AD components and dem-
onstrate the universal efficacy of the KZip+ with the Split
GAL4 system.
Applications of KZip+
The Boolean “NOT” operation effected by KZip+ on Split
GAL4 expression patterns enables two principle applications
with respect to a cell group of interest. First, KZip+ can
remove cells from a Split GAL4 expression pattern that may
confound an experiment, leaving only the cells of interest to
be selectively labeled or manipulated. Second, KZip+ can
eliminate the cells of interest from a Split GAL4 expression
pattern to determine the effects of their selective exclusion
frommanipulations performed on the entire pattern. The first
application is useful because the probability of finding com-
pletely cell type-specific Split GAL4 lines is low. The second
application is useful in instances where systematic, functional
interrogation of different subpopulations within a Split GAL4
pattern is desirable.
To illustrate the utility of eliminating unwanted expression
fromaSplitGAL4pattern,weexaminedahemidriver pair that
expresses in the larval Mushroom Body (MB Split GAL4; Fig-
ure 4A), a brain region which has been the focus of consider-
able study (Heisenberg 2003). The larval MB expression is
coupled with unwanted expression in neurons of the VNC
in third-instar larvae. This was eliminated by driving
KZip+::3xHA under the control of teashirt-LexA (J.-M. Knapp
and J. Simpson, unpublished data), which expresses predom-
inantly in VNC neurons (Figure 4B). Similarly, by driving
LexAop-KZip+::3xHA under the control of the glial-specific
LexA line (Lai and Lee 2006), nonneuronal glia cells were re-
moved from the expression pattern of a Split GAL4 hemidriver
pair that otherwise expresses in a single olfactory interneuron
of the lateral horn (Figure S3). KZip+ can thus remove unde-
sired expression from Split GAL4-generated patterns to sub-
stantially reduce the number of cells within the pattern.
As an illustration of the second application of KZip+ de-
scribed above, namely to functionally interrogate neurons
within a Split GAL4 expression pattern, we used the KZip+
-p10 construct to investigate the function of two different
subsets of neurons that express the Shaw K+ channel. Shaw
is expressed in CCAP-expressing neurons, including those
that express bursicon, and its previously demonstrated im-
portance in wing expansion is likely due, at least in part, to its
activity in those neurons (Hodge et al. 2005). However, the
channel is also expressed in many other neurons (Diao et al.
2015) and we sought to determine whether these non-CCAP-
expressing neurons might also play a role in wing expansion.
We first used the cold-activated ion channel TRPM8 to dem-
onstrate that activation of either all Shaw-expressing neurons
(ShawMI01735-p65AD\elav-GAL4DBD; Figure 5A) or the sub-
population that expresses CCAP (ShawMI01735-p65AD\CCAP-
GAL4DBD; Figure 5B) induces rapid wing expansion, as
expected. We then examined the functional consequences
of activating the subpopulation of Shaw-expressing neu-
rons that do not express CCAP (Figure 5C). We find that
flies in which UAS-TRPM8 expression is specifically blocked
in the CCAP-expressing neurons by CCAP-KZip+-p10 do
Figure 4 Anatomically parsing neural circuitry with the Killer Zipper
(KZip+). (A) Confocal projection view of a third-instar larval CNS whole-
mount expressing Upstream Activating Sequence (UAS)-csChrimson::
mVenus (green) under the control of the MB Split GAL4 line (126E12-
p65AD\103H02-DBD). Magenta; neuropil labeling by anti-N-cadherin
antibody. Yellow bracket; ventral nerve cord (vnc). br; brain. (B) Confocal
image from the CNS of a similar animal additionally expressing LexAop-
KZip+::3xHA under the control of the teashirt-LexA driver (tsh-LexA),
which expresses primarily in the VNC (yellow bracket). Expression of KZip+
suppresses reporter expression in the VNC (genotypes of animals in (A)
and (B) were identical except for the presence of the teashirt-LexA driver
transgene). Bar, 30 mm. Each image is a representative of n . 15 brains
per genotype.
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not expand their wings significantly more rapidly than
control flies. These results indicate that, among Shaw-
expressing neurons, those that also express CCAP are pri-
marily, if not solely, responsible for inducing rapid wing
expansion and illustrate the utility of KZip+ in the func-
tional decomposition of different cell types within an ex-
pression pattern.
Discussion
The Split GAL4 system is widely used in Drosophila to map
neural circuits, and the KZip+ technology introduced here
significantly extends the capabilities of that system by pro-
viding a method for rationally and reproducibly subdividing
the expression patterns of Split GAL4 drivers. It does so by
robustly repressing Split GAL4 activity within defined subsets
of neurons and is therefore capable of suppressing the expres-
sion UAS-transgenes encoding both reporters, such as UAS-
EGFP, and effectors, such as UAS-TRPM8. We demonstrate
the effectiveness of KZip+ bothwhen it is expressed under the
control of specific enhancers, such as CCAP or Bursa, and
when its expression is amplified under the control of LexA
drivers. The toolbox of KZip+ constructs and fly lines pre-
sented here should thus be broadly useful in making refined
anatomical and functional manipulations to support circuit
mapping efforts in Drosophila.
The utility of KZip+ in restricting the expression pattern of
any given Split GAL4 driver will, of course, depend upon the
Figure 5 KZip+-p10 identifies the subset of
Shaw-expressing neurons that promote wing
expansion. (A) Top: the shaw gene is
expressed in a subset of CCAP-expressing
neurons identified by the Split GAL4 driver
ShawMI01735- p65AD\CCAP-GAL4DBD driv-
ing UAS-EGFP-TRPM8 (green). CCAP neurons
are identified by anti-CCAP immunolabeling
(magenta) and the double-labeled Shaw-
expressing subset appears white. EGFP-
TRPM8 expression was detected by anti-GFP
immunolabeling and for all panels. Bar,
50 mm. Bottom: Inset of the double-labeled
subset within the dotted rectangle in the top
panel. (B) Top: the full pattern of shaw gene
expression in the nervous system—revealed
by the ShawMI01735-p65AD\elav-GAL4DBD
Split GAL4 driver—includes not only CCAP-
expressing neurons (magenta, with double-la-
beled neurons appearing white), but also
many other neurons as indicated by UAS-
EGFP-TRPM8 expression (green). Bottom: Inset
as in (A). (C) Top: KZip+ expression driven by
the CCAP promoter, selectively suppresses
Split GAL4 activity in the CCAP neurons,
which now do not express the UAS-EGFP-
TRPM8 and are labeled only by anti-CCAP
(magenta). Bottom: inset as in (A) showing
the subset of Shaw- and CCAP-expressing
neurons, in which Split GAL4 activity—and
therefore TRPM8 expression—is suppressed
by KZip+. (D) Box plots show the wing expan-
sion times for flies with the genotypes repre-
sented in (A)–(C), in which the cold-sensitive
ion channel UAS-TRPM8 is expressed in: only
CCAP-expressing Shaw neurons (A), all Shaw
neurons (B), or all Shaw neurons except those
expressing CCAP (C). Flies of the first two
types expand rapidly at 18 Compared to
25 by virtue of TRPM8 activation in CCAP-
expressing neurons at the lower temperature
[asterisks indicate a significant difference in
wing expansion time (P , 0.05) at the two
temperatures as determined by Bonferroni-
adjusted Welch’s t-tests]. In contrast, flies in
which KZip+ prevents UAS-TRPM8 expression in CCAP-expressing neurons show no significant difference in wing expansion times at the two temper-
atures. br, brain; CCAP, Crustacean Cardioactive Peptide; DBD, DNA-binding domain; EGFP, enhanced GFP; KZip+, Killer Zipper; UAS, Upstream
Activating Sequence; vnc, ventral nerve cord.
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availability of enhancers that can be used to drive its expres-
sion in desired cell groups. A distinct advantage of the
LexAop-KZip+ fly lines introduced here is that they can be
used with the growing number of publicly available LexA
driver lines that express either in functionally defined neuro-
nal groups (e.g., neurons that use a particular neurotransmit-
ter Diao et al. 2015; Simpson 2016) or in neuronal patterns
that have been extensively characterized and archived in
searchable databases so that their likely overlap with a Split
GAL4 pattern of interest can be accessed (http://flweb.janelia.
org/cgi-bin/flew.cgi). An increasing number of well-character-
ized Split GAL4 lines is similarly becoming available as part of
ongoing efforts at the Janelia Research Campus to generate a
set of 4000 Split GAL4 lines that can be used to specifically
target transgene expression to most cell types of the fly ner-
vous system (https://www.janelia.org/project-team/flylight),
and KZip+ should complement these efforts.
Finally, because KZip+ acts within the Split GAL4 system
analogously to GAL80 within the GAL4-UAS system, tools
that exploit GAL80’s repressor function to refine patterns of
GAL4-driven transgene expression can be readily adapted for
use in the Split GAL4 system. Such tools include FLP-out
GAL80 (Struhl and Basler 1993) and FINGR (Bohm et al.
2010), both of which have been used successfully for neural
circuit mapping (Gordon and Scott 2009; Rezaval et al. 2012;
Alekseyenko et al. 2013; Flood et al. 2013; Pool et al. 2014).
Implementing these strategies with KZip+ will, however,
necessitate the introduction of additional transgenes into
genetic crosses, which may become a limitation.
The KZip+ technology introduced here requires the
incorporation of up to two transgenes into genetic crosses
in addition to the three transgenes required for Split GAL4-
mediated expression of a reporter or effector. This number of
transgenes is readily accommodated in the fly, and while it
may be more challenging to accommodate this number of
transgenes in other organisms, ternary expression systems
that use the same leucine zippers as Split GAL4 exist in both
Caenorhabditis elegans (Wei et al. 2012) and zebrafish
(Almeida and Lyons 2015). Our technology should thus be
readily extendable to such organisms. Here, as in flies,
achieving sufficiently refined neuronal targeting has been a
major limitation, and our hope is that KZip+ may broadly
facilitate neural circuit mapping studies in multiple genetic
model organisms.
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